Prognostic value of auto-antibodies in the serum of Omani patients with gastric cancer

Saudi Medical Journal

Volumn 27, Issue 12, 2006, Pages 1873-1877

  Al Shukaili, Ahmed K ^a   Al Jabri, Ali A ^a   Al Moundhari, Mansour S ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CELL NUCLEUS ANTIGEN; DOUBLE STRANDED DNA ANTIBODY; JO 1 ANTIBODY; LA ANTIBODY; MITOCHONDRION ANTIBODY; MYELOBLASTIN; MYELOPEROXIDASE; PARIETAL CELL ANTIBODY; RETICULIN; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SCL 70 ANTIBODY; SM ANTIBODY; SMOOTH MUSCLE ANTIBODY;

ADULT; AGED; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL DEPARTMENT; HUMAN; HUMAN CELL; KIDNEY PARENCHYMA; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OMAN; PREVALENCE; PROGNOSIS; STOMACH; STOMACH CANCER; UNIVERSITY HOSPITAL; BLOOD; MIDDLE AGED; STOMACH TUMOR;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OMAN; PROGNOSIS; STOMACH NEOPLASMS;

EID: 39049185668     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ehrenfeld M, Abu-Shakra M, Buskila D, Shoenfeld Y. The dual association between lymphoma and autoimmunity. Blood Cells Mol Dis 2001; 27: 750-756.
2. Swissia M, Cohen Y, Shoenfeld Y. Autoantibodies in the sera of patients with lymphoma. Leuk Lymphoma 1992; 7: 117-122.
3. Chiou SH, Sheu BC, Chang WC, Huang SC, Hong-Nerng H. Current concepts of tumor-infiltrating lymphocytes in human malignancies. J Reprod Immunol 2005; 67: 35-50.
4. Solans-Laque R, Perez-Bocanegra C, Salud-Salvia A, Fonollosa-Pla V. Rodrigo MJ, Armadans L, et al. Clinical significance of antinuclear antibodies in malignant diseases: Association with rheumatic and connective tissue paraneoplastic syndromes. Lupus 2004; 13: 159-164.
5. Swissa M, Amital-Teplizki H, Haim N, Cohen Y, Shoenfeld Y. Autoantibodies in neoplasia. An unresolved enigma. Cancer 1990; 65: 2554-2558.
6. Ito M, Haruma K, Kaya S, Kai H, Masuda H, Ohta M, et al. Implication of anti-parietal cell antibody levels in gastrointestinal diseases, including gatric carcinogenesis. Dig Dis Sci 2002; 47: 1080-1085.
7. Atalay C, Atalay G, Yilmaz KB, Altinok A. The role of anti-CENP-B and anti-SS-B antibodies in breast cancer. Neoplasma 2005; 52: 32-35.
8. Konstandoulakis NM, Syrigos KN, Leandros M, Charalabopoulos A, Manouras A, Golematis BC. Autoantibodies in the serum of patients with gastric cancer: Their prognostic importance. Hybridoma 1998; 17: 431-435.
9. Chung JK, Park YJ, Kim TY, So Y, Kim SK, Park DJ, et al. Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation. Clin Endocrinol 2002; 57: 215-221.
10. Fernandez-Madrid F, VandeVord PJ, Yang X, Karvonen RL, Simpson PM, Kraut MJ, et al. Antinuclear antibodies as potential markers of lung cancer. Clin Cancer Res 1999; 5: 1393-1400.
11. Zuber M. Positive antinuclear antibodies in malignancies. Ann Rheum Dis 1992; 51: 573-574.
12. Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2O04; 34: 501-537.
13. Wenzel J, Gerdsen R, Uerlich M, Bauer R, Bieber T, Boehm I. Antibodies targeting extractable nulear antigens: Historical development and current knowledge. Br J Dermatol 2001; 145: 859-867.
14. Phan TG, Wong RC, Adelstein S. Autoantibodies to extractable nuclear antigens: Making detection and interpretation more meaningful. Clin Diagn Lab Immunol 2002; 9: 1-7.
15. Gergely L, Danko A, Csipo I, Varoczy L, Sipka S, Zeher M, et al. Antibodies against extractable nuclear antigen in non-Hodgkin lymphomna patients. Scand J Immmunol 2005; 61: 343-346.
16. Wakelee HA, Sikic BI. Activity of novel cytotoxic agents in lung cancer: epothilones and topoisomerase I inhibitors. Clin Lung Cancer 2005; 7: S6-S12.
17. Pope JE. Scleroderma overlaps syndromes. Curr Opin Rheumatol 2002; 14: 704-710.
18. Lerner A, Kumar V, Iancu TC. Immunological diagnosis of childhood coeliac disease: Comparison between antigliadin, antireticulin and antiendomysial antibodies. Clin Exp Immunol 1994; 95: 79-82.
19. Al-Jabri AA, Al-Belushi MS, Nsanze H, Frequency and levels of autoantibodies in healthy adult Omanis. Ann Saudi Med 2003; 23: 372-375.
20. Kurki R, Linder E, Miettinen A, Alfthan O, Heikkinen A, Pasternack A. Tissue antibodies in malignant and benign urogenital disease. Int J Cancer 1977; 19: 332-336.
21. Syrigos KN, Konstantoulakis MM, Fyssas I, Katsilambros N, Golematis BC. Autoantibodies against insulin and beta-islet cells in pancreatic adenocarcinoma: A possible explanation for diabetes mellitus. Int J Cancer 1996; 66: 624-626
22. Fyssas I, Syrigos KN. Konstantoulakis MM, Tsibloulis V, Manouras A, Peveretos P, et al. Thyroid autoantibodies and thyroid function in patients with pancreatic adenocarcinoma. Acta Oncol 1997; 36: 65-68.
23. Reitzig P, Apostoloff E, Wildner GP, Gutz HJ. Irro F. Parietal cell antibodies and stomach cancer. Arch Geschwulstforsch 1983; 53: 341-344.